Learn more Last week was a bad one for rocket company Rocket Lab (NASDAQ:RKLB). It plunged on news that it would be delaying the launch of Neutron, which is now not expected to take place until next ...

Scientists at Cold Spring Harbor Laboratory have discovered that a protein linked to cancer growth can also strengthen immune ...

India, Oct. 18 -- The Indian laboratory consumable industry supplies essential products to pharmaceutical companies, ...

Each of these aspiring players has big potential in a massive market, but each has some clear weak spots, too.

Anthropic’s Q3 revenue rose 45% sequentially, compared to 147% growth in the preceding quarter, according to Anthropic’s ...

Rocket Lab disclosed that inspections revealed a flaw that requires a full redesign and process change. Jim Cramer says this ...

Management's schedule for positive adjusted EBITDA hinges on that first launch. Has the sell-off priced in the wait?

A protein known for promoting cancer may hold an unexpected key to fighting it. New research reveals how manipulating immune ...

Rocket Lab has shed nearly a fifth of its value in one week while sitting on a record backlog and a wall of analyst buy ...

Postdoctoral scholars at UC San Diego are on the frontlines to some of the most groundbreaking discoveries in areas ...

Rocket Lab stock sinks as company delays Neutron’s debut flight to 2027. KeyBanc trimmed its price target on RKLB shares.

Colorectal cancer has become the leading cause of cancer-related death for people under 50. Its most common forms generally ...